PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer
PARP 抑制剂的疗效取决于在 BRCA 缺陷型三阴性乳腺癌模型中通过肿瘤内 STING 通路激活进行的 CD8+ T 细胞募集
期刊:Cancer Discovery
影响因子:29.7
doi:10.1158/2159-8290.CD-18-1218
Constantia Pantelidou #, Olmo Sonzogni #, Mateus De Oliveria Taveira, Anita K Mehta, Aditi Kothari, Dan Wang, Tanvi Visal, Michelle K Li, Jocelin Pinto, Jessica A Castrillon, Emily M Cheney, Peter Bouwman, Jos Jonkers, Sven Rottenberg, Jennifer L Guerriero, Gerburg M Wulf, Geoffrey I Shapiro
